Precision Medicine in AD: Castle Biosciences’ Pipeline AD Test Aims to Change the Way Your Patients Are Treated October 25, 2025
Fall Clinical 2025 News: Castle’s DecisionDx-Melanoma Stratifies Risk Across Histological Subtypes October 24, 2025
Fall Clinical 2025 News: Oral Icotrokinra Shows High Clearance in Difficult-to-treat Scalp and Genital Psoriasis October 24, 2025